Trial Profile
A study investigating the relationship between serum BAFF levels and B cell subsets in different lymphoid organs after Rituximab administration in patients with immunological high risks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Immunological disorders
- Focus Therapeutic Use
- 27 Dec 2015 New trial record